Comparative Pharmacology
Head-to-head clinical analysis: SIMVASTATIN versus ZYPITAMAG.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SIMVASTATIN versus ZYPITAMAG.
SIMVASTATIN vs ZYPITAMAG
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. Reduces hepatic cholesterol synthesis, increases LDL receptor expression, and lowers plasma LDL cholesterol.
ZYPITAMAG (pitavastatin magnesium) is a competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to reduced intracellular cholesterol and upregulation of LDL receptors.
10-40 mg orally once daily in the evening; maximum 80 mg/day.
2-4 mg orally once daily, at any time of day, with or without food.
None Documented
None Documented
The terminal elimination half-life of simvastatin is approximately 2-3 hours, but for the active metabolite (simvastatin acid) it is about 1.9 hours; clinical lipid-lowering effects persist longer due to sustained HMG-CoA reductase inhibition.
Clinical Note
moderateSimvastatin + Levofloxacin
"The serum concentration of Levofloxacin can be increased when it is combined with Simvastatin."
Clinical Note
moderateSimvastatin + Norfloxacin
"The serum concentration of Norfloxacin can be increased when it is combined with Simvastatin."
Clinical Note
moderateSimvastatin + Prednisolone
"The serum concentration of Prednisolone can be increased when it is combined with Simvastatin."
Clinical Note
moderateSimvastatin + Resveratrol
Terminal elimination half-life: 12 hours (range 10-14 h) in healthy subjects; supports once-daily dosing
Primarily hepatic metabolism, with approximately 13% excreted in urine as metabolites and 60% in feces via biliary elimination; less than 0.5% of the active form is excreted unchanged in urine.
Primarily renal (93% as unchanged pitavastatin and metabolites) via active tubular secretion; fecal (5%)
Category D/X
Category C
Statin
Statin
"The serum concentration of Resveratrol can be increased when it is combined with Simvastatin."